Target Price | $5.10 |
Price | $1.06 |
Potential |
381.13%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target TherapeuticsMD, Inc. 2026 .
The average TherapeuticsMD, Inc. target price is $5.10.
This is
381.13%
register free of charge
$5.25
395.28%
register free of charge
$5.05
376.42%
register free of charge
|
|
A rating was issued by 6 analysts: 0 Analysts recommend TherapeuticsMD, Inc. to buy, 3 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the TherapeuticsMD, Inc. stock has an average upside potential 2026 of
381.13%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 1.76 | 9.28 |
35.38% | 427.39% | |
Net Margin | -123.86% | 44.50% |
84.34% | 135.93% |
3 Analysts have issued a sales forecast TherapeuticsMD, Inc. 2025 . The average TherapeuticsMD, Inc. sales estimate is
This results in the following potential growth metrics:
2024 | $1.8m | 35.38% |
---|---|---|
2025 |
$9.3m
427.39%
Unlock
|
3 TherapeuticsMD, Inc. Analysts have issued a net profit forecast 2025. The average TherapeuticsMD, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
2024 | $-2.2m | 78.79% |
---|---|---|
2025 |
$4.1m
289.45%
Unlock
|
2024 | -123.86% | 84.34% |
---|---|---|
2025 |
44.50%
135.93%
Unlock
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.20 | 0.36 |
79.59% | 280.00% | |
P/E | 2.97 | |
EV/Sales | 0.67 |
3 Analysts have issued a TherapeuticsMD, Inc. forecast for earnings per share. The average TherapeuticsMD, Inc. EPS is
This results in the following potential growth metrics and future valuations:
2024 | $-0.20 | 79.59% |
---|---|---|
2025 |
$0.36
280.00%
Unlock
|
Current | -21.20 | 484.83% |
---|---|---|
2025 |
2.97
114.01%
Unlock
|
Based on analysts' sales estimates for 2025, the TherapeuticsMD, Inc. stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
Current | 2.42 | 85.34% |
---|---|---|
2025 |
0.67
72.40%
Unlock
|
Current | 4.79 | 77.95% |
---|---|---|
2025 |
1.32
72.42%
Unlock
|
TherapeuticsMD, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.